Trial Profile
Clinical Trials Insight: 700057392
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jul 2010
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors MannKind Corporation
- 29 Jun 2010 New trial record
- 26 Jun 2010 Two-year efficacy results reported at American Diabetes Society (ADA) meeting, according to a Mannkind Corporation media release.